Palm Research Center is currently enrolling participants in two different type 1 diabetes clinical trials studying different types of meal time (bolus) insulin. Participating in a clinical trial helps to drive scientific progress that will deliver new treatments and therapies to make day-to-day life with T1D easier, safer and healthier. It is part of the Breakthrough T1D mission of curing, preventing, and treating T1D and its complications.

Qualified participants may receive study related medical exams, laboratory tests, investigational medication, and compensation for time and travel for participation in a study.

The current studies vary in length from 6 – 12 months.

Enrollment criteria include:

• Type 1 Diabetes
• Age 18-79
• A1c <11%

For questions about how to enroll in this opportunity or for more information on Breakthrough T1D sponsored TrialNet research (testing family members at risk for T1D), contact Palm Research Center at 702-826-2795.